These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4655566)

  • 21. [Effect of asparagine on hepatic physiopathological syndromes].
    Fodor O; Cotul S; Barbarino F; Grigoras D; Nicoară A; Suciu A
    Stud Cercet Med Interna; 1968; 9(5):405-14. PubMed ID: 5716055
    [No Abstract]   [Full Text] [Related]  

  • 22. [Corticoid therapy in liver diseases].
    Runcan V; Buligescu L
    Med Interna (Bucur); 1970 Mar; 22(3):259-64. PubMed ID: 5444364
    [No Abstract]   [Full Text] [Related]  

  • 23. [Corticosteroid therapy in hepatic diseases].
    Mazzacca G
    Recenti Prog Med; 1967 Jul; 43(1):51-70. PubMed ID: 4302862
    [No Abstract]   [Full Text] [Related]  

  • 24. [D-penicillamine therapy in liver diseases. Preliminary results in 44 cases].
    Alexander M; Wille G
    MMW Munch Med Wochenschr; 1974 Feb; 116(5):211-6. PubMed ID: 4205097
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hepagrisevit forte in chronic liver diseases].
    Kollatz E; Kramer A; Schopper W; Siede W
    Med Klin; 1965 Dec; 60(50):2032-5. PubMed ID: 5331151
    [No Abstract]   [Full Text] [Related]  

  • 26. [Thiomesterone and liver function].
    Pickert H
    Med Klin; 1968 Aug; 63(31):1222-6. PubMed ID: 5719699
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical study of the effect of the administration of cathergen preparation in patients with chronic hepatic lesions].
    Maleev A; Tsvetkova V; Krŭstev Z; Kostova N; Lukanov L
    Vutr Boles; 1985; 24(5):39-43. PubMed ID: 4090451
    [No Abstract]   [Full Text] [Related]  

  • 28. [The anti-steatosic effect of sulfo-adenosylmethionine (SAMe) in various forms of chronic hepatopathy. Multicentric research].
    Mazzanti R; Arcangeli A; Salvadori G; Smorlesi C; Di Perri T; Auteri A; Boggiano CA; Pippi L; Toti M; Boncompagni P; Angioli D; Caremani M; Magnolfi F; Camarri E; Motta R; Forconi A; Candidi Tommasi A; Lomi M; Soldi A
    Minerva Med; 1978 Oct; 69(48):3283-92. PubMed ID: 724140
    [No Abstract]   [Full Text] [Related]  

  • 29. [Indications, method and effectiveness of immunosuppressive treatment in chronic active hepatopathies. I. Changes in the general dynamics of the disease. II. Slowing-down of the chronicization process].
    Nicolaescu T; Stoiculescu P; Bittman E; Bordeianu A; Gheorghe N; Pintilescu V; Metz L
    Med Interna (Bucur); 1974 Apr; 26(4):453-64. PubMed ID: 4839352
    [No Abstract]   [Full Text] [Related]  

  • 30. [Pharmaco-metabolic activity in chronic hepatopathies: influence of treatment with UDPG].
    Okolicsànyi L; Orlando R; Lirussi F; Naccarato R; Dal Brun G
    Clin Ter; 1980 May; 93(4):431-8. PubMed ID: 6998643
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of patients with chronic liver diseases with a hepatotrophic preparation].
    Pagliaro L
    Minerva Med; 1971 Jul; 62(57):2840-3. PubMed ID: 4105219
    [No Abstract]   [Full Text] [Related]  

  • 32. [Therapy of chronic liver diseases with prednisolone and alpha-lipoic acid].
    Loginow AS
    Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):19-23. PubMed ID: 4925665
    [No Abstract]   [Full Text] [Related]  

  • 33. [The treatment of inflammatory liver diseases with 6-mercaptopurine (6-MP)].
    Weinreich J
    Acta Hepatosplenol; 1967; 14(4):189-98. PubMed ID: 5589685
    [No Abstract]   [Full Text] [Related]  

  • 34. [Immunoglobulins and histological findings in chronic liver diseases treated with immunosuppressive agents].
    Bauch K; Büttner W; Lewicki I; Zimmermann S; Dempe A
    Z Gesamte Inn Med; 1973 Jun; 28(11):Suppl:169-72. PubMed ID: 4728086
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of diffuse liver diseases with balanced doses of vitamin B12, folic acid, ascorbic acid and nicotinamide].
    Perez Mota A
    Rev Esp Enferm Apar Dig; 1968; 27(6):933-44. PubMed ID: 4242995
    [No Abstract]   [Full Text] [Related]  

  • 36. [Studies on bilirubin glucuronide. I. A study on the relation of bilirubin glucuronide in bile and liver damage].
    Takagi M
    Igaku Kenkyu; 1969 Jun; 39(3):255-64. PubMed ID: 5389947
    [No Abstract]   [Full Text] [Related]  

  • 37. The treatment of chronic liver diseases by means of an extralysate of liver.
    Kallai L; Kocić J
    Arzneimittelforschung; 1969 Jun; 19(6):1030-1. PubMed ID: 5820032
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of chronic liver diseases with thioctic acid].
    Möller E; Brinkmann W; Weber O; Wildhirt E
    Med Klin; 1967 Mar; 62(10):380-4. PubMed ID: 4874626
    [No Abstract]   [Full Text] [Related]  

  • 39. The natural history of hepatitis-associated (Australia)-antigen (HAA)-positive chronic liver disease.
    Dudley FJ; Scheuer PJ; Sherlock S
    Gut; 1972 Oct; 13(10):852. PubMed ID: 5087111
    [No Abstract]   [Full Text] [Related]  

  • 40. [Results of glucocorticoid therapy in liver diseases].
    Möller E; Brinkmann W; Weber O
    Med Welt; 1967 Apr; 14():884-9. PubMed ID: 5585085
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.